Journal article · 2024 · Open access

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Mohsen Naghavi, Stein Emil Vollset, Kevin Shunji Ikuta, Lucien R Swetschinski, Authia P Gray, Eve E Wool, Gisela Robles Aguilar, Tomislav Meštrović, Georgia Smith, Chieh Han, Rebecca L. Hsu, Julian Chalek and 513 more

The Lancet, 404(10459), 1199–1226 · Published 1 September 2024 · DOI 10.1016/s0140-6736(24)01867-1

Read the free full textCite this paper

In brief

“Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050” is a 2024 journal article by Mohsen Naghavi and 524 co-authors, published in The Lancet. OpenAlex counts 4,978 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at The Lancet.

Citations
4,978
Most cited in
2026 (2,975)
Field-weighted impact
1441.29
References
66
Authors
525

Abstract

BACKGROUND: Antimicrobial resistance (AMR) poses an important global health challenge in the 21st century. A previous study has quantified the global and regional burden of AMR for 2019, followed with additional publications that provided more detailed estimates for several WHO regions by country. To date, there have been no studies that produce comprehensive estimates of AMR burden across locations that encompass historical trends and future forecasts. METHODS: We estimated all-age and age-specific deaths and disability-adjusted life-years (DALYs) attributable to and associated with bacterial AMR for 22 pathogens, 84 pathogen-drug combinations, and 11 infectious syndromes in 204 countries and territories from 1990 to 2021. We collected and used multiple cause of death data, hospital discharge data, microbiology data, literature studies, single drug resistance profiles, pharmaceutical sales, antibiotic use surveys, mortality surveillance, linkage data, outpatient and inpatient insurance claims data, and previously published data, covering 520 million individual records or isolates and 19 513 study-location-years. We used statistical modelling to produce estimates of AMR burden for all locations, including those with no data. Our approach leverages the estimation of five broad component quantities: the number of deaths involving sepsis; the proportion of infectious deaths attributable to a given infectious syndrome; the proportion of infectious syndrome deaths attributable to a given pathogen; the percentage of a given pathogen resistant to an antibiotic of interest; and the excess risk of death or duration of an infection associated with this resistance. Using these components, we estimated disease burden attributable to and associated with AMR, which we define based on two counterfactuals; respectively, an alternative scenario in which all drug-resistant infections are replaced by drug-susceptible infections, and an alternative scenario in which all drug-resistant infections were replaced by no infection. Additionally, we produced global and regional forecasts of AMR burden until 2050 for three scenarios: a reference scenario that is a probabilistic forecast of the most likely future; a Gram-negative drug scenario that assumes future drug development that targets Gram-negative pathogens; and a better care scenario that assumes future improvements in health-care quality and access to appropriate antimicrobials. We present final estimates aggregated to the global, super-regional, and regional level. FINDINGS: In 2021, we estimated 4·71 million (95% UI 4·23-5·19) deaths were associated with bacterial AMR, including 1·14 million (1·00-1·28) deaths attributable to bacterial AMR. Trends in AMR mortality over the past 31 years varied substantially by age and location. From 1990 to 2021, deaths from AMR decreased by more than 50% among children younger than 5 years yet increased by over 80% for adults 70…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Aguilar, G. R., Meštrović, T., Smith, G., Han, C., Hsu, R. L., Chalek, J., Araki, D. T., Chung, E., Raggi, C., Hayoon, A. G., Weaver, N. D., Lindstedt, P. A., Smith, A. E., . . . Murray, C. J. L. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet, 404(10459), 1199–1226. https://doi.org/10.1016/s0140-6736(24)01867-1

MLA 9

Naghavi, Mohsen, et al. “Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050.” The Lancet, vol. 404, no. 10459, 2024, pp. 1199–1226. https://doi.org/10.1016/s0140-6736(24)01867-1.

Chicago

Naghavi, Mohsen, Stein Emil Vollset, Kevin Shunji Ikuta, Lucien R Swetschinski, Authia P Gray, Eve E Wool, Gisela Robles Aguilar, et al. 2024. “Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050.” The Lancet 404 (10459): 1199–1226. https://doi.org/10.1016/s0140-6736(24)01867-1.

Harvard

Naghavi, M. et al. (2024) ‘Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050’, The Lancet, 404(10459), pp. 1199–1226. doi:10.1016/s0140-6736(24)01867-1.

IEEE

M. Naghavi et al., “Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050,” The Lancet, vol. 404, no. 10459, pp. 1199–1226, 2024, doi: 10.1016/s0140-6736(24)01867-1.

BibTeX

@article{naghavi2024global,
  title     = {{Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050}},
  author    = {Naghavi, Mohsen and Vollset, Stein Emil and Ikuta, Kevin Shunji and Swetschinski, Lucien R and Gray, Authia P and Wool, Eve E and Aguilar, Gisela Robles and Meštrović, Tomislav and Smith, Georgia and Han, Chieh and Hsu, Rebecca L. and Chalek, Julian and Araki, Daniel T and Chung, Erin and Raggi, Catalina and Hayoon, Anna Gershberg and Weaver, Nicole Davis and Lindstedt, Paulina A and Smith, Amanda Elizabeth and Altay, Umut and Bhattacharjee, Natalia V. and Giannakis, Konstantinos and Fell, Frederick and McManigal, Barney and Ekapirat, Nattwut and Mendes, Jessica Andretta and Runghien, Tilleye and Srimokla, Oraya and Abdelkader, Atef F. I. and Abd-Elsalam, Sherief Mohamed and others},
  journal   = {The Lancet},
  year      = {2024},
  volume    = {404},
  number    = {10459},
  pages     = {1199--1226},
  doi       = {10.1016/s0140-6736(24)01867-1},
  url       = {https://doi.org/10.1016/s0140-6736(24)01867-1}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201911
202244
202311
2024140140
20251,8571857
20262,9752975

Its field-weighted citation impact is 1441.29: it has been cited 1441.29 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance

  • antimicrobial resistance
  • bacterial infection
  • disease burden
  • disability-adjusted life years
  • sepsis
  • infectious syndromes
  • antibiotic resistance
  • Gram-negative bacteria

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Aguilar, G. R., Meštrović, T., Smith, G., Han, C., Hsu, R. L., Chalek, J., Araki, D. T., Chung, E., Raggi, C., Hayoon, A. G., Weaver, N. D., Lindstedt, P. A., Smith, A. E., . . . Murray, C. J. L. (2024). Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. The Lancet, 404(10459), 1199–1226. https://doi.org/10.1016/s0140-6736(24)01867-1

How many times has this paper been cited?

4,978 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at The Lancet.

Who wrote this paper?

Mohsen Naghavi, Stein Emil Vollset, Kevin Shunji Ikuta, Lucien R Swetschinski, Authia P Gray, Eve E Wool, Gisela Robles Aguilar, Tomislav Meštrović, Georgia Smith, Chieh Han, Rebecca L. Hsu, Julian Chalek and 513 more.

What is the DOI of this paper?

10.1016/s0140-6736(24)01867-1. The permanent link is https://doi.org/10.1016/s0140-6736(24)01867-1.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.